CLOBEX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Clobex, and what generic alternatives are available?
Clobex is a drug marketed by Galderma Labs Lp and Galderma Labs and is included in three NDAs.
The generic ingredient in CLOBEX is clobetasol propionate. There are fourteen drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Clobex
A generic version of CLOBEX was approved as clobetasol propionate by COSETTE on February 16th, 1994.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CLOBEX?
- What are the global sales for CLOBEX?
- What is Average Wholesale Price for CLOBEX?
Summary for CLOBEX
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 3 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 80 |
| Clinical Trials: | 14 |
| Patent Applications: | 4,476 |
| Drug Prices: | Drug price information for CLOBEX |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for CLOBEX |
| What excipients (inactive ingredients) are in CLOBEX? | CLOBEX excipients list |
| DailyMed Link: | CLOBEX at DailyMed |
Recent Clinical Trials for CLOBEX
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| MC2 Therapeutics | Phase 1 |
| Drug Delivery Solutions Ltd. (part of MC2 Therapeutics) | Phase 1 |
| University of California, San Francisco | Phase 4 |
Pharmacology for CLOBEX
| Drug Class | Corticosteroid |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Paragraph IV (Patent) Challenges for CLOBEX
| Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
|---|---|---|---|---|---|---|
| CLOBEX | Spray | clobetasol propionate | 0.05% | 021835 | 1 | 2008-09-29 |
| CLOBEX | Topical Shampoo | clobetasol propionate | 0.05% | 021644 | 1 | 2008-01-09 |
| CLOBEX | Lotion | clobetasol propionate | 0.05% | 021535 | 1 | 2006-03-27 |
US Patents and Regulatory Information for CLOBEX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Galderma Labs Lp | CLOBEX | clobetasol propionate | LOTION;TOPICAL | 021535-001 | Jul 24, 2003 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Galderma Labs | CLOBEX | clobetasol propionate | SHAMPOO;TOPICAL | 021644-001 | Feb 5, 2004 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Galderma Labs Lp | CLOBEX | clobetasol propionate | SPRAY;TOPICAL | 021835-001 | Oct 27, 2005 | AT | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CLOBEX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Galderma Labs Lp | CLOBEX | clobetasol propionate | LOTION;TOPICAL | 021535-001 | Jul 24, 2003 | ⤷ Sign Up | ⤷ Sign Up |
| Galderma Labs | CLOBEX | clobetasol propionate | SHAMPOO;TOPICAL | 021644-001 | Feb 5, 2004 | ⤷ Sign Up | ⤷ Sign Up |
| Galderma Labs | CLOBEX | clobetasol propionate | SHAMPOO;TOPICAL | 021644-001 | Feb 5, 2004 | ⤷ Sign Up | ⤷ Sign Up |
| Galderma Labs Lp | CLOBEX | clobetasol propionate | SPRAY;TOPICAL | 021835-001 | Oct 27, 2005 | ⤷ Sign Up | ⤷ Sign Up |
| Galderma Labs Lp | CLOBEX | clobetasol propionate | SPRAY;TOPICAL | 021835-001 | Oct 27, 2005 | ⤷ Sign Up | ⤷ Sign Up |
| Galderma Labs | CLOBEX | clobetasol propionate | SHAMPOO;TOPICAL | 021644-001 | Feb 5, 2004 | ⤷ Sign Up | ⤷ Sign Up |
| Galderma Labs | CLOBEX | clobetasol propionate | SHAMPOO;TOPICAL | 021644-001 | Feb 5, 2004 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for CLOBEX
See the table below for patents covering CLOBEX around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Russian Federation | 2193388 | ПЕННАЯ КОМПОЗИЦИЯ ДЛЯ УХОДА ЗА ВОЛОСАМИ (FROTHY COMPOSITION FOR TAKING CARE FOR HAIR) | ⤷ Sign Up |
| Japan | 4091257 | ⤷ Sign Up | |
| European Patent Office | 1695691 | Composition moussante pour le lavage et le traitement des cheveux (Foaming composition for hair cleaning and hair treatment) | ⤷ Sign Up |
| European Patent Office | 0832647 | Nouvelles compositions topiques sous forme d'émulsion fluide H/E à forte teneur en glycol pro-pénétrant (Topical oil-in-water fluid emulsions having a high content of glycol) | ⤷ Sign Up |
| Australia | 695806 | ⤷ Sign Up | |
| Canada | 2333427 | COMPOSITION MOUSSANTE POUR LE SOIN DES CHEVEUX (FOAMING COMPOSITION FOR HAIR CARE) | ⤷ Sign Up |
| Russian Federation | 2001101891 | ⤷ Sign Up | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
